Kaiser Permanente, Antioch, CA, United States of America.
Kaiser Permanente, Division of Research, Oakland, CA, United States of America.
Thromb Res. 2021 Feb;198:99-102. doi: 10.1016/j.thromres.2020.11.034. Epub 2020 Dec 2.
• Patients who warrant chronic warfarin can safely continue warfarin therapy with precautions during the COVID-19 pandemic. • Chronic warfarin therapy is not associated with a higher rate of positively testing for SAR-CoV2. • Patients on warfarin during the COVID-19 pandemic maintained TTR rates consistent with those prior to the COVID-19 pandemic.
• 在 COVID-19 大流行期间,需要长期接受华法林治疗的患者可以在采取预防措施的情况下安全地继续华法林治疗。• 长期接受华法林治疗与 SARS-CoV2 检测呈阳性的比率升高无关。• COVID-19 大流行期间接受华法林治疗的患者的 TTR 率与 COVID-19 大流行之前的 TTR 率一致。